StockTipsArenaBeta

BUY Marksans Pharma Limited — Rajesh Satpute

BUYMarksans Pharma Limited
Marksans Pharma share price target & all analyst calls

byRajesh SatputeHorizon: Swing (≤2wk)29 Sept 2026via CNBC Awaaz.

Entry₹341.4Inferred
Target₹360
Total upside +5.45% (call closed)
Stop loss₹330-3.34% risk
Exit₹33030 Sept 2026, 10:00 am
Stop-loss hit-3.34%
Follow Rajesh Satpute for new calls(29% target hit, 163 closed calls)Get alertsWatch MARKSANS for new buy/sell callsGet alertsSee 1 active Swing call on MARKSANSSee 157 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 30 Sept, 4:41 pm IST
2 supporting2 neutral0 opposing
Supports the BUY call (2)

2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·29 Sept · today

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·29 Sept · today

Neutral / worth noting (2)

Marksans Pharma Opens SEBI-Mandated Window for Re-Lodging Physical Share Transfers

NewsGoogle News·17 Sept · 2w ago

(opens in new tab)

Marksans Pharma opens special window for re-lodgement of physical share transfer requests

NewsGoogle News·17 Sept · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.